Atara Biotherapeutics(DE:AT20)
€6.10+0.30 (+5.17%)
DE:AT20
Atara Biotherapeutics earnings date
€6.10
At close:+0.30 (+5.17%)
Atara Biotherapeutics (AT20) Q2 2022 Earnings Report
0 Followers
DE:AT20 Q2 2022 EPS Results
- Actual EPS
- EUR 4.10
- Consensus EPS
- -EUR 18.15
- Beat/Miss
- Beat by +EUR 22.25
- One Year Ago EPS
- -EUR 20.75
DE:AT20 Q2 2022 Revenue Results
- Actual Revenue
- EUR 47.04M
- Expected Revenue
- EUR 6.24M
- Beat/Miss
- Beat by +EUR 40.80M
- YoY Revenue Growth
- +1232.79%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- After Close
- Conference Call
- Monday, August 8, 2022
DE:AT20 Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AT20 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.03- | -0.23 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.12-0.14 | -0.29 | 53.13% (+0.16) | |
| Aug 12, 2026 | 2026 (Q2) | -0.29-0.29 | 0.17 | -268.42% (-0.47) | |
| May 12, 2026 | 2026 (Q1) | -0.30-0.26 | 3.19 | -108.29% (-3.46) | |
| Mar 16, 2026 | 2025 (Q4) | -0.16-0.23 | -1.09 | 78.99% (+0.86) | |
| Nov 29, 2025 | 2025 (Q3) | -0.61-0.29 | -2.67 | 89.08% (+2.38) | |
| Aug 11, 2025 | 2025 (Q2) | -0.060.17 | -2.83 | 106.13% (+3.00) | |
| May 15, 2025 | 2025 (Q1) | -1.813.19 | -5.24 | 160.87% (+8.44) | |
| Mar 07, 2025 | 2024 (Q4) | -2.61-1.09 | -12.77 | 91.50% (+11.68) | |
| Nov 12, 2024 | 2024 (Q3) | -1.72-2.67 | -15.05 | 82.24% (+12.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

